In this study, SGLT2 inhibition-associated renal protection was mediated by the elevation of ketone bodies, which suppressed the mechanistic target of rapamycin complex1 (mTORC1) signaling (as assessed by phosphorylation of the S6 protein) hyperactivation, thereby alleviating DKD (69). The gene discussed is SLC5A2; the disease is diabetic kidney disease.